Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status

Size: px
Start display at page:

Download "Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status"

Transcription

1 Journal of Clinical Densitometry, vol. 10, no. 3, 239e243, 2007 Ó Copyright 2007 by The International Society for Clinical Densitometry /07/10:239e243/$32.00 DOI: /j.jocd Original Article Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status Gary M. Kiebzak,*,1 Kenneth G. Faulkner, 2 Wynn Wacker, 3 Ronald Hamdy, 4 Edith Seier, 5 and Nelson B. Watts 6 1 Center for Orthopaedic Research and Education, St. Luke s Belmont Center, Houston, TX; 2 Synarc, San Francisco, CA; 3 GE Healthcare, Madison, WI; 4 Osteoporosis Center, College of Medicine, East Tennessee State University and VAMC, Johnson City, TN; 5 Department of Mathematics, East Tennessee State University, Johnson City, TN; and 6 University of Cincinnati College of Medicine, Cincinnati, OH Abstract We quantified confidence intervals (CIs) for T-scores for the lumbar spine and hip and determined the practical effect (impact on diagnosis) of variability around the T-score cutpoint of 2.5. Using precision data from the literature for GE Lunar Prodigy dual-energy X-ray absorptiometry (DXA) systems, the 95% CI for the T-score was G0.23 at the lumbar spine (L1eL4), G 0.20 at the total hip, and G0.41 at the femoral neck. Thus, T-score variations of G0.23 or less at the spine, G0.20 at the total hip, and G0.41 at the femoral neck are not statistically significant. When diagnosing osteoporosis, T-scores in the interval 2.3 to 2.7 for spine or total hip (after rounding to conform to guidelines from the International Society for Clinical Densitometry) and 2.1 to 2.9 for femoral neck are not statistically different from 2.5. Better precision values resulted in smaller 95% CIs. This concept was applied to actual clinical data using Hologic DXA systems. The study cohort comprised 2388 white women with either normal or osteopenic spines in whom the densitometric diagnosis of osteoporosis would be determined by hip T- scores. When evaluating actual patient T-scores in the range 2.5 G 95% CI, we found that the diagnosis was indeterminate in approximately 12% of women when T-scores for femoral neck were used and in 4% of women when T-scores for total hip were used, with uncertainty as to whether the classification was osteopenia or osteoporosis. We conclude that precision influences the variability around T-scores and that this variability affects the reliability of diagnostic classification. Key Words: Bone mineral density; dual-energy X-ray absorptiometry; DXA; precision error; T-score. Introduction The least significant change (LSC) value for bone mineral density (BMD) accounts for measurement variability (precision) and determines when change in BMD between 2 measurements is statistically significant (1e3). Although not commonly taken into account, precision also influences Received 01/29/07; Revised 03/07/07; Accepted 03/10/07. *Address correspondence to: Gary M. Kiebzak, PhD, Center for Orthopaedic Research and Education, St. Luke s Belmont Center, 2909 W. Holcombe Blvd, Houston, TX gkiebzak@ sleh.com a single-point BMD measurement, resulting in statistical uncertainty in the BMD and therefore uncertainty regarding the T-score (4). This variability around a T-score introduces uncertainty of diagnosis when evaluating bone status for patients with T-scores near the transition threshold between normal and osteopenia (T-score 5 1) and between osteopenia and osteoporosis (T-score 5 2.5) (5). According to basic statistics, there is a range of T-scores above and below 2.5 within which T-scores are not significantly different from 2.5 and from each other. That is, confidence intervals (CIs) around the T-score of 2.5 exist, based on the precision of the measurement, which define a range within which T-scores are statistically equivalent. Within 239

2 240 Kiebzak et al. that range, T-scores are indeterminate with respect to diagnostic classification; i.e., diagnosis can be statistically uncertain using a T-score from a single dual-energy X-ray absorptiometry (DXA) scan. The primary objective of this study was to define the 95% CI around the diagnostic T-score threshold of 2.5 and to show how precision error can affect the size of the 95% CI. The secondary objective was to estimate the percentage of patients who may have an uncertain diagnosis (either osteopenic or osteoporotic) as a result of the indeterminate range of T-scores defined by the 95% CI. Methods The description of methods and the results each consist of 2 sections. The first section describes the calculation of the 95% CI for a T-score and demonstrates the effect of precision error using actual data collected in the field from GE DXA systems. The second section applies the concept to a cohort of women who were scanned on a Hologic DXA system to show the percentage of patients who would have an indeterminate diagnosis based on hip T-scores. Use of both GE and Hologic data demonstrates the generalizability of the concept of a 95% CI for a T-score. The Concept of Variability Around a T-score: Defining the 95% CI for a T-score The 95% CI for a T-score depends on both accurate and precise measurements. For a properly calibrated DXA system using an accepted reference population, accuracy errors will not be significant, and the CI for the T-score will be solely a function of the precision error. Assuming BMD is normally distributed, the 95% CI for a single T-score measurement can be estimated from the properties of the normal distribution (6). The 95% CI of a single T-score assessment is determined from the equation: 95% CI 5 T-score ð1:96þðprecision errorþ Population SD where Precision 5 the root mean square standard deviation (SD) for a set of repeat measures. This value is obtained by a precision assessment, which must be done at every DXA center. Population SD 5 the SD of the manufacturer s reference population used to calculate the T-score. The 1.96 coefficient in the equation represents the 95% range in the normal distribution necessary to compute the 95% CI. Reported precision errors for expert DXA centers (centers that are research oriented and conduct clinical trials, etc.) and clinical DXA centers (such as small private practice centers) were used (Table 1) (7). Using the GE Lunar Prodigy DXA system (GE Healthcare, Madison, WI), the expert precision error (g/cm 2 ) in women (age, 63 G 9 yr, mean G SD) was for the L1eL4 spine, for the femoral neck, Table 1 Expert and Clinical Precision Errors (g/cm 2 ) With the GE Lunar Prodigy Expert Clinical Note: See Ref. (7). and for the total hip region. At clinical centers using the GE Lunar Prodigy, precision error in women (age, yr) was reported as at the L1eL4 spine, at the femoral neck, and at the total hip. Table 2 shows the population SDs used in the GE Lunar EnCore software (8). Application of Concept to a Cohort of Patients The center s measurement precision using a Hologic Delphi DXA system (software version 11.1; Waltham, MA) was determined using triplicate measurements in 15 patients with repositioning between scans. Patients used in the center s precision assessment were representative of the center s patient population. The precision (g/cm 2 ) was for the femoral neck and for the total hip. The 95% CIs for femoral neck and total hip were calculated as above using our center s precision data and the manufacturer s reference population SDs, which are g/cm 2 for femoral neck and g/ cm 2 for total hip(8). We retrospectively reviewed DXA data collected from 1997 to Data were evaluated for all Caucasian women O50 yr of age who had lumbar spine and bilateral hip scans performed in the same scanning session. Women were excluded if BMD was affected by documented pathology or technical issues such as positioning of the proximal femur for scanning. A total of 3012 patients were identified. The mean age was 64 yr, range, 50e92 yr. T-scores were calculated for lumbar spine L1eL4, right and left total hip, and femoral neck from the standard Hologic reference database (manufacturer-specific spine database and NHANES III for hip). Bone status was determined from the lowest T-score, and patients were classified as normal, osteopenic, or osteoporotic using International Society for Clinical Densitometry (ISCD) and World Health Organization (WHO) criteria (9,10). Table 2 Population Standard Deviations (SDs) Used to Calculate T-scores for GE Lunar Prodigy L1eL4 spine Femoral neck Total hip Population SD (g/cm 2 ) Note: See Ref. (8).

3 Confidence Limits for T-Scores 241 From this cohort, we identified women with normal and osteopenic spines for whom a diagnosis of osteoporosis would be based on T-scores from the hip scan. There were 1229 women with normal spines and 1159 women with osteopenic spines. We determined the percentage of women with total hip and femoral neck T-scores within the range defined by the 95% CI around 2.5 (after rounding to conform to the guidelines of the ISCD) (11), namely, 2.3 to 2.7 for total hip and 2.2 to 2.8 for femoral neck for this particular DXA system. Results Defining 95% CIs for T-scores Using representative precision values for Prodigy DXA systems from clinical centers, the 95% CI for T-scores at each skeletal site were G0.23 at the lumbar spine, G0.20 at the total hip, and 0.41 at the femoral neck (Table 3). Around the T-score of 2.5, these 95% CIs defined ranges of 2.27 to 2.73 for the spine, 2.30 to 2.70 for the total hip, and 2.09 to 2.91 for the femoral neck, respectively. By statistical standards, T-scores within each range would not be significantly different from each other, and not different from 2.5. The influence of precision values on the calculated 95% CIs and T-score ranges around 2.5 are summarized in Tables 3 and 4 and Fig. 1, showing that the better the precision, the smaller the indeterminate range around 2.5. Application of Concept to Study Cohort Table 5 summarizes the percentage of women with T- scores in the range defined by 2.5 G 95% CI. The larger the 95% CI, the larger the indeterminate range, as seen by comparing the percentage of women identified using femoral neck vs total hip T-scores. Compared with women with normal spines, more women with osteopenic spines had hip T-scores in the indeterminate range. Discussion This study illustrated the concept that variation exists around a single T-score, just as it exists for any single-point measurement. The degree of variation is predominantly determined by a center s measurement precision; the better the precision, the smaller the indeterminate range of T-scores Table 3 Average T-score 95% Confidence Intervals for Expert and Clinical Centers Using GE Lunar Prodigy Dual-Energy X-Ray Absorptiometry Systems Expert Clinical Table 4 Indeterminate T-Score Range Around T-score 2.5 Defined by 95% Confidence Intervals for Expert and Clinical Centers Using GE Lunar Prodigy Dual-Energy X-Ray Absorptiometry Systems Expert Clinical 2.34 to to to to to to 2.70 Note: In clinical practice, T-scores would normally be rounded to one decimal place per International Society for Clinical Densitometry guidelines (11). and vice versa. When applied to the diagnostic thresholds T-score and 2.5, there will be patients whose diagnostic classification will be uncertain (indeterminate) based on a single DXA scan. In such cases, clinical judgment will be necessary with respect to management decisions. Although not commonly taken into account, this concept should be considered in clinical decision making. T-scores have been adopted by the field of densitometry in an effort to standardize reporting of DXA scan results, as absolute BMD values differ substantially at different skeletal sites and between DXA systems from different manufacturers (12). The WHO subsequently used T-scores to designate a densitometric definition of osteoporosis as a T-score of 2.5. However, despite being originally intended as a population definition, the WHO definition of osteoporosis has become a diagnostic standard for individuals as well. Having a threshold definition (i.e., a T-score defining a category) creates the problem of interpretation of values close to the threshold. Some physicians may adhere to strict definitions and not classify a patient as osteoporotic until the lowest T- score is 2.5. In addition, strict interpretation of threshold guidelines may restrict commencement of treatment until specific T-score thresholds have been reached. T-score Accuracy Limit (95% CI) Expert Sites Clinical Sites L1-L4 Spine Femoral Neck Total femur Fig. 1. Average T-score accuracy errors (95% confidence intervals) for expert and clinical centers. See Ref. (7).

4 242 Kiebzak et al. Table 5 Percent of Patients Who Could Not Be Definitively Diagnosed as Osteoporotic Due to Indeterminate T-Scores a Spine status Normal (n ) Osteopenic (n ) All patients (n ) Left total hip Percent of patients for each skeletal site Right total hip Left FN Right FN Abbr: FN, femoral neck. Notes: Patients had both left and right hips scanned in the same session. If the spine was normal or osteopenic based on L1eL4 T- score, then the densitometric diagnosis of osteoporosis would be determined by the status of the hips if a hip T-score was 2.5. T-scores were rounded to one decimal place per International Society for Clinical Densitometry guidelines (11). a Indeterminate T-score ranges are defined as 2.5 G 95% confidence interval: total hip, 2.3 to 2.7; FN, 2.2 to 2.8. Our results suggest that when managing an individual patient, clinicians should not become overly focused on either a single T-score result or a fixed threshold defining categories of bone status. In bone densitometry, rigid adherence to thresholds could negatively impact patient management. For example, suppose a center s 95% CI for T-scores at femoral neck is G0.4 with an indeterminate range of T-scores of 2.1 to 2.9. If an untreated postmenopausal woman has a femoral neck T-score of 2.3, then there is little justification to withhold treatment until lower T-scores are obtained because 2.3 is not significantly different from 2.5. All of the patients in our clinical cohort who we considered to have indeterminate T-scores had T-scores! 2.0, which is the threshold suggested by the National Osteoporosis Foundation for initiating treatment. Thus, these patients could have commenced treatment without requiring a T-score of 2.5 or lower. Finally, although we have not provided examples in this article, the concept of variation around T-scores should also be applied to the WHO definition of osteopenia at a T-score threshold of 1.0. Recognition of variation around a single T-score raises 2 important issues. First, densitometrists must realize that the skeletal site with the worst precision at their center will also have the greatest diagnostic uncertainty. For many centers, femoral neck precision is not as good as total hip precision (13). This is somewhat problematic in that femoral neck has been designated the preferred site to define osteoporosis (14). Second, consideration should be given to the benefit of duplicate scans and routine bilateral hip scans as a method to help resolve classification uncertainties when a T-score from a single scan is in the indeterminate range (5,15). Increasing the number of scans and taking the average value will narrow the 95% CI and improve the measurement confidence (1). In summary, T-scores are subject to measurement variation just like any other test. For clinical DXA centers, the 95% CI can be reduced by reducing the precision error to levels that have been demonstrated at expert DXA centers. Our results underscore the need for each DXA center to determine its own precision error. Not only is knowledge of precision important for determining the LSC, which is used to monitor change, but as we have shown, precision is also important for determining the certainty of a diagnosis. That is, if a patient s T-score is within the indeterminate range of values around a diagnostic threshold (T-score 5 1 or 2.5), then it may not be possible to definitively classify bone status as normal, osteopenia, or osteoporosis. Finally, in any case, a diagnosis of osteoporosis and fracture risk assessment should not rely entirely on a single T-score: it is important to take into account patient factors such as age and history of atraumatic fracture. References 1. Bonnick SL, Johnston CC Jr, Kleerekoper M, Lindsay R, Miller P, Sherwood L, Siris E Importance of precision in bone density measurements. J Clin Densitom 4(2):105e Gluer CC, Blake G, Lu Y, Blunt BA, Jergas M, Genent HK Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 5(4):262e Lenchik L, Kiebzak GM, Blunt BA What is the role of serial bone mineral density measurements in patient management? J Clin Densitom 5(Suppl):S29eS Faulkner KG, Weynand LS, Wacker WK, Barden HS Determination of T-score confidence limits for diagnosing osteoporosis. J Clin Densitom 9(2):237. [abstract]. 5. Kiebzak GM, Hamdy RC, Seier E, Watts NB Variability around the T-score cutpoint of -2.5 impacts diagnostic classification. J Clin Densitom 8(2):238. [abstract]. 6. Zar JH Biostatistical analysis. 2nd ed. Prentice Hall, Englewood Cliffs, NJ. 7. Weynand LS, Barden HS, Faulkner KG Precision of fanbeam densitometers in clinical practice. J Bone Miner Res 19(Suppl 1):S235. [abstract]. 8. Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA. Appendix vi. pp WHO Assessment of fracture risk and its application to screening for postmenopausal osteoporosis WHO Technical Report Series Hamdy RC, Petak SM, Lenchik L Which central dual x-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitom 5(Suppl):S11eS The Writing Group for the ISCD Position Development Conference 2004 Nomenclature and decimal places in bone densitometry. J Clin Densitom 7(1):45e49.

5 Confidence Limits for T-Scores Faulkner KG The tale of the T-score: review and perspective. Osteoporos Int 16:347e Shepherd JA, Lu Y, Wilson K, et al Cross-calibration and minimum precision standards for dual-energy x-ray absorptiometry: the 2005 ISCD Official Positions. J Clin Densitom 9(1):31e Hans D, Downs RW, Duboeuf F, Greenspan S, Jankowski LG, Kiebzak GM, Petak SM Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions. J Clin Densitom 9(1):15e Hamdy R, Kiebzak GM, Seier E, Watts NB The prevalence of significant left-right differences in hip bone mineral density. Osteoporos Int 17:1772e1780.

Quality Control of DXA System and Precision Test of Radio-technologists

Quality Control of DXA System and Precision Test of Radio-technologists J Bone Metab 2014;21:2-7 http://dx.doi.org/10.11005/jbm.2014.21.1.2 pissn 2287-6375 eissn 2287-7029 Review Article Quality Control of DXA System and Precision Test of Radio-technologists Ho-Sung Kim 1,

More information

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi Clinical Utility of Bone Densitometry Diagnosis (DXA)

More information

Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems?

Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems? Osteoporos Int (2010) 21:1227 1236 DOI 10.1007/s00198-009-1062-3 ORIGINAL ARTICLE Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems? B. Fan & Y. Lu

More information

The official position of the International Society for Clinical

The official position of the International Society for Clinical Improving Clinical Decisions for Women at Risk of Osteoporosis: Dual-Femur Bone Mineral Density Testing Raymond E. Cole, DO, CCD Context: In bone mineral density (BMD) testing, unilateral hip analysis

More information

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA ORIGINAL ARTICLE Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA Leila Amiri 1, Azita Kheiltash 2, Shafieh Movassaghi 1, Maryam Moghaddassi 1, and Leila Seddigh 2 1 Rheumatology

More information

DXA Best Practices. What is the problem? 9/29/2017. BMD Predicts Fracture Risk. Dual-energy X-ray Absorptiometry: DXA

DXA Best Practices. What is the problem? 9/29/2017. BMD Predicts Fracture Risk. Dual-energy X-ray Absorptiometry: DXA BMD Predicts Fracture Risk Ten Year Fracture Probability (%) 50 40 30 20 10 Age 80 70 60 50 E. Michael Lewiecki, MD Director, New Mexico Clinical Research & Osteoporosis Center Director, Bone TeleHealth

More information

9 Quality Assurance in Bone Densitometry section

9 Quality Assurance in Bone Densitometry section 9 Quality Assurance in Bone Densitometry section Introduction Bone densitometry is frequently used to determine an individual's fracture risk at a particular point in time but may also be used to assess

More information

Documentation, Codebook, and Frequencies

Documentation, Codebook, and Frequencies Documentation, Codebook, and Frequencies Dual-Energy X-ray Absorptiometry Femur Bone Measurements Examination Survey Years: 2005 to 2006 SAS Transport File: DXXFEM_D.XPT January 2009 NHANES 2005 2006 Data

More information

Purpose. Methods and Materials

Purpose. Methods and Materials Prevalence of pitfalls in previous dual energy X-ray absorptiometry (DXA) scans according to technical manuals and International Society for Clinical Densitometry. Poster No.: P-0046 Congress: ESSR 2014

More information

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11. NIH Public Access Author Manuscript Published in final edited form as: Endocr Pract. 2013 ; 19(5): 780 784. doi:10.4158/ep12416.or. FRAX Prediction Without BMD for Assessment of Osteoporotic Fracture Risk

More information

Special report on the official positions of the International Society for Clinical Densitometry

Special report on the official positions of the International Society for Clinical Densitometry Osteoporos Int (2004) 15: 779 784 DOI 10.1007/s00198-004-1677-3 POSITION PAPER Special report on the official positions of the International Society for Clinical Densitometry E.M. Lewiecki Æ D.L. Kendler

More information

THE INTERNATIONAL SOCIETY for Clinical Densitometry

THE INTERNATIONAL SOCIETY for Clinical Densitometry 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(8):3651 3655 Printed in U.S.A. Copyright 2004 by The Endocrine Society doi: 10.1210/jc.2004-0124 POSITION STATEMENT Official

More information

2013 ISCD Official Positions Adult

2013 ISCD Official Positions Adult 2013 ISCD Official Positions Adult These are the Official Positions of the ISCD as updated in 2013. The Official Positions that are new or revised since 2007 are in bold type. Indications for Bone Mineral

More information

Screening points for a peripheral densitometer of the calcaneum for the diagnosis of osteoporosis

Screening points for a peripheral densitometer of the calcaneum for the diagnosis of osteoporosis 23 Ivorra Cortés J, Román-Ivorra JA, Alegre Sancho JJ, Beltrán Catalán E, Chalmeta Verdejo I, Fernández-Llanio Comella N, Muñoz Gil S Servicio de Reumatología - Hospital Universitario Dr. Peset - Valencia

More information

Measurement Uncertainty in Spine Bone Mineral Density by Dual Energy X-ray Absorptiometry

Measurement Uncertainty in Spine Bone Mineral Density by Dual Energy X-ray Absorptiometry J Bone Metab 2017;24:105-109 https://doi.org/10.11005/jbm.2017.24.2.105 pissn 2287-6375 eissn 2287-7029 Original Article Measurement Uncertainty in Spine Bone Mineral Density by Dual Energy X-ray Absorptiometry

More information

Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen

Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen Christian Muschitz II. Medizinische Abteilung mit Rheumatologie, Osteologie & Gastroenterologie Akademisches Lehrkrankenhaus

More information

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT Original Article Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT Objective: To compare Fracture Risk Assessment Tool (FRAX) calculations with and without bone

More information

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster DOI 10.1007/s00296-012-2460-y ORIGINAL ARTICLE Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security

More information

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Use of DXA / Bone Density in the Care of Your Patients Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Important Websites Resources for Clinicians and Patients www.nof.org www.iofbonehealth.org

More information

Obesity Increases Precision Errors in Total Body Dual X-ray Absorptiometry Measurements.

Obesity Increases Precision Errors in Total Body Dual X-ray Absorptiometry Measurements. Obesity Increases Precision Errors in Total Body Dual X-ray Absorptiometry Measurements. 1 K.M.Knapp, 1 J.R.Welsman, 1 S.J.Hopkins, 1 A.Shallcross, 2 I.Fogelman and 2 G.M.Blake 1. University of Exeter,

More information

Skeletal Sites for Osteoporosis Diagnosis: The 2005 ISCD Official Positions

Skeletal Sites for Osteoporosis Diagnosis: The 2005 ISCD Official Positions Journal of Clinical Densitometry, vol. 9, no. 1, 15 21, 2006 Ó Copyright 2006 by The International Society for Clinical Densitometry 1094-6950/06/9:15 21/$32.00 DOI: 10.1016/j.jocd.2006.05.003 Position

More information

Validation of the Osteoporosis Self-Assessment Tool in US Male Veterans

Validation of the Osteoporosis Self-Assessment Tool in US Male Veterans Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health, vol. 17, no. 1, 32e37, 2014 Published by Elsevier Inc. on behalf of The International Society for Clinical Densitometry

More information

Prodigy. from GE Healthcare. Most trusted, reliable and best-selling DXA system with one of the largest installed base in the world. gehealthcare.

Prodigy. from GE Healthcare. Most trusted, reliable and best-selling DXA system with one of the largest installed base in the world. gehealthcare. Prodigy from GE Healthcare Most trusted, reliable and best-selling DXA system with one of the largest installed base in the world gehealthcare.com Prodigy High performance, efficient and reliable DXA system

More information

Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women

Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women International Endocrinology Volume 3, Article ID 895474, 5 pages http://dx.doi.org/.55/3/895474 Clinical Study Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women Na Li, Xin-min

More information

PhenX Measure: Body Composition (#020300) PhenX Protocol: Body Composition - Body Composition by Dual-Energy X-Ray Absorptiometry (#020302)

PhenX Measure: Body Composition (#020300) PhenX Protocol: Body Composition - Body Composition by Dual-Energy X-Ray Absorptiometry (#020302) PhenX Measure: Body Composition (#020300) PhenX Protocol: Body Composition - Body Composition by Dual-Energy X-Ray Absorptiometry (#020302) Date of Interview/Examination (MM/DD/YYYY): A downloadable PDF

More information

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.

More information

ORIGINAL INVESTIGATION. Single-Site vs Multisite Bone Density Measurement for Fracture Prediction

ORIGINAL INVESTIGATION. Single-Site vs Multisite Bone Density Measurement for Fracture Prediction ORIGINAL INVESTIGATION Single-Site vs Multisite Bone Density Measurement for Fracture Prediction William D. Leslie, MD, MSc; Lisa M. Lix, PhD; James F. Tsang, BSc; Patricia A. Caetano, PhD; for the Manitoba

More information

Diagnosis of Vertebral Fractures by Vertebral Fracture Assessment

Diagnosis of Vertebral Fractures by Vertebral Fracture Assessment Journal of Clinical Densitometry, vol. 9, no. 1, 66 71, 2006 Ó Copyright 2006 by The International Society for Clinical Densitometry 1094-6950/06/9:66 71/$32.00 DOI: 10.1016/j.jocd.2005.11.002 Original

More information

Norland Densitometry A Tradition of Excellence

Norland Densitometry A Tradition of Excellence Norland Densitometry A Tradition of Excellence Norland DXA Bone Density Measurement Osteoporosis is a disease marked by reduced bone strength leading to an increased risk of fractures. About 54 million

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Osteoporosis- Do We Need to Think Beyond Bone Mineral Density? Dr Preeti Soni 1, Dr Shipra

More information

Lunar idxa. The intelligent DXA. gehealthcare.com

Lunar idxa. The intelligent DXA. gehealthcare.com Lunar idxa The intelligent DXA gehealthcare.com The best of DXA technology for bone and metabolic health assessment With a state-of-the-art design, Lunar idxa offers research-grade image resolution and

More information

Quality Assurance and Control in Dual energy X ray Absorptiometry

Quality Assurance and Control in Dual energy X ray Absorptiometry Mihail A. Boyanov Quality Assurance and Control in Dual energy X ray Absorptiometry Sofia, 2013 Central Medical Library Quality Assurance and Control in Dual energy X ray Absorptiometry Mihail A. Boyanov,

More information

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis

More information

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction Asian Spine Journal Asian Spine Clinical Journal Study Asian Spine J 2014;8(6):729-734 High http://dx.doi.org/10.4184/asj.2014.8.6.729 risk patients with osteopenia How Many High Risk Korean Patients with

More information

Clinical Densitometry

Clinical Densitometry Volume 8 Number 3 Fall 2005 ISSN: 1094 6950 Journal of Clinical Densitometry The Official Journal of The International Society for Clinical Densitometry Editor-in-Chief Paul D. Miller, MD HumanaJournals.com

More information

Cross-reference: MP Whole Body Dual X-Ray Absorptiometry (DEXA) to Determine Body Composition MP Bone Mineral Density

Cross-reference: MP Whole Body Dual X-Ray Absorptiometry (DEXA) to Determine Body Composition MP Bone Mineral Density Original Issue Date (Created): April 26, 2011 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY Screening for vertebral fractures using dual x-ray absorptiometry

More information

Available online at ScienceDirect. Osteoporosis and Sarcopenia 1 (2015) 109e114. Original article

Available online at  ScienceDirect. Osteoporosis and Sarcopenia 1 (2015) 109e114. Original article HOSTED BY Available online at www.sciencedirect.com ScienceDirect Osteoporosis and Sarcopenia 1 (2015) 109e114 Original article Localized femoral BMD T-scores according to the fracture site of hip and

More information

2013 ISCD Combined Official Positions

2013 ISCD Combined Official Positions 2013 ISCD Combined Oicial Positions Oicial Positions of the International Society for Clinical Densitometry The International Society for Clinical Densitometry (ISCD) is a not-for-profit multidisciplinary

More information

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines Osteoporos Int (2006) 17: 1111 1115 DOI 10.1007/s00198-006-0101-6 SHORT COMMUNICATION An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines R. Baddoura. H. Awada. J. Okais.

More information

Obesity Increases Precision Errors in Dual X-ray Absorptiometry Measurements.

Obesity Increases Precision Errors in Dual X-ray Absorptiometry Measurements. Obesity Increases Precision Errors in Dual X-ray Absorptiometry Measurements. 1 K.M.Knapp, 1 J.R.Welsman, 1 S.J.Hopkins, 2 I.Fogelman and 2 G.M.Blake 1. University of Exeter, Exeter, UK 2. King s College

More information

Annotations Part III Vertebral Fracture Initiative. International Osteoporosis Foundation March 2011

Annotations Part III Vertebral Fracture Initiative. International Osteoporosis Foundation March 2011 Annotations Part III Vertebral Fracture Initiative International Osteoporosis Foundation March 2011 Slide 1-3 Topics to be covered: What is vertebral fracture assessment? How does VFA compare to standard

More information

Name of Policy: Vertebral Fracture Assessment with Dual X-Ray Absorptiometry (DEXA)

Name of Policy: Vertebral Fracture Assessment with Dual X-Ray Absorptiometry (DEXA) Name of Policy: Vertebral Fracture Assessment with Dual X-Ray Absorptiometry (DEXA) Policy #: 202 Latest Review Date: June 2014 Category: Radiology Policy Grade: D Background/Definitions: As a general

More information

Concordance of a Self Assessment Tool and Measurement of Bone Mineral Density in Identifying the Risk of Osteoporosis in Elderly Taiwanese Women

Concordance of a Self Assessment Tool and Measurement of Bone Mineral Density in Identifying the Risk of Osteoporosis in Elderly Taiwanese Women TZU CHI MED J September 2008 Vol 20 No 3 available at http://ajws.elsevier.com/tcmj Tzu Chi Medical Journal Original Article Concordance of a Self Assessment Tool and Measurement of Bone Mineral Density

More information

QCT and CT applications in Osteoporosis Imaging

QCT and CT applications in Osteoporosis Imaging Q appli in Osteoporosis Imaging Thomas M. Link, MD, PhD Department of Radiology Biomedical Imaging University of California, San Francisco Goals 1. To identify advantages disadvantages of Q compared to

More information

Prevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p.

Prevalence of Osteoporosis p. 262 Consequences of Osteoporosis p. 263 Risk Factors for Osteoporosis p. 264 Attainment of Peak Bone Density p. Dedication Preface Acknowledgments Continuing Education An Introduction to Conventions in Densitometry p. 1 Densitometry as a Quantitative Measurement Technique p. 2 Accuracy and Precision p. 2 The Skeleton

More information

Factors Associated with Treatment Initiation after Osteoporosis Screening

Factors Associated with Treatment Initiation after Osteoporosis Screening American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 160, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwh245 Factors Associated with

More information

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

Official Positions on FRAX

Official Positions on FRAX 196 96 DEPLIANT 3,5x8,5.indd 1 2010 Official Positions on FRAX 21.03.11 11:45 Interpretation and Use of FRAX in Clinical Practice from the International Society for Clinical Densitometry and International

More information

Validation and comparative evaluation of four osteoporosis risk indexes in Moroccan menopausal women

Validation and comparative evaluation of four osteoporosis risk indexes in Moroccan menopausal women DOI 10.1007/s11657-006-0001-6 ORIGINAL ARTICLE Validation and comparative evaluation of four osteoporosis risk indexes in Moroccan menopausal women Abdellah El Maghraoui & Amine Habbassi & Mirieme Ghazi

More information

University of Groningen. Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert

University of Groningen. Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert University of Groningen Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

Osteoporosis/Fracture Prevention

Osteoporosis/Fracture Prevention Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team

More information

Healthy aging. It s vital.

Healthy aging. It s vital. GE Healthcare Healthy aging. It s vital. encore 17 The leading edge of DXA applications This trio of new encore 17 functions will take your clinical assessment capability to the next level. We are pleased

More information

Bone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda

Bone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda Bone Mineral Density in a Cohort of Young Adult Women using Depoprovera and Tenofovir, Kampala, Uganda Flavia Matovu Kiweewa, Noah Kiwanuka, Delia Scholes, Esther Isingel, Mary Glenn Fowler, Clemensia

More information

Journal of Biomedical Graphics and Computing, 2014, Vol. 4, No. 2

Journal of Biomedical Graphics and Computing, 2014, Vol. 4, No. 2 ORIGINAL RESEARCH Short-term precision error in dual energy x-ray absorptiometry, bone mineral density and trabecular bone score measurements; and effects of obesity on precision error Susan J Hopkins,

More information

Measuring Bone Mineral Density

Measuring Bone Mineral Density Measuring Bone Mineral Density Osteoporosis Screening by Pharmacists 9/20/06 Don Downing Institute for Innovative Pharmacy Practice Today s Topics What is osteoporosis? What causes osteoporosis? Screening

More information

Medical Policy. MP Vertebral Fracture Assessment With Densitometry

Medical Policy. MP Vertebral Fracture Assessment With Densitometry Medical Policy BCBSA Ref. Policy: 6.01.44 Last Review: 09/19/2018 Effective Date: 09/19/2018 Section: Radiology Related Policies 6.01.40 Whole Body Dual X-Ray Absorptiometry to Determine Body Composition

More information

OSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO

OSTEOPOROSIS IN MEN. Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO OSTEOPOROSIS IN MEN Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Speakers Bureau: Amgen, Radius Consultant: Abbvie, Amgen, Janssen, Radius, Sanofi Watts NB et

More information

DXA scanning to diagnose osteoporosis: Do you know what the results mean?

DXA scanning to diagnose osteoporosis: Do you know what the results mean? REVIEW CME CREDIT BRADFORD RICHMOND, MD Department of Radiology, The Cleveland Clinic; certification instructor, the International Society for Clinical Densitometry DXA scanning to diagnose osteoporosis:

More information

University of Groningen. Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert

University of Groningen. Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert University of Groningen Osteoporosis, identification and treatment in fracture patients de Klerk, Gijsbert IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

Bone Mineral and Body Composition Measurements: Cross-Calibration of Pencil-Beam and Fan-Beam Dual- Energy X-Ray Absorptiometers*

Bone Mineral and Body Composition Measurements: Cross-Calibration of Pencil-Beam and Fan-Beam Dual- Energy X-Ray Absorptiometers* JOURNAL OF BONE AND MINERAL RESEARCH Volume 13, Number 10, 1998 Blackwell Science, Inc. 1998 American Society for Bone and Mineral Research Bone Mineral and Body Composition Measurements: Cross-Calibration

More information

Research Article Whole-Body versus Local DXA-Scan for the Diagnosis of Osteoporosis in COPD Patients

Research Article Whole-Body versus Local DXA-Scan for the Diagnosis of Osteoporosis in COPD Patients SAGE-Hindawi Access to Research Journal of Osteoporosis Volume 2010, Article ID 640878, 6 pages doi:10.4061/2010/640878 Research Article Whole-Body versus Local DXA-Scan for the Diagnosis of Osteoporosis

More information

Understanding the Development of Osteoporosis and Preventing Fractures: WHO Do We Treat Now?

Understanding the Development of Osteoporosis and Preventing Fractures: WHO Do We Treat Now? Understanding the Development of Osteoporosis and Preventing Fractures: WHO Do We Treat Now? Steven M. Petak, MD, JD, FACE, FCLM Texas Institute for Reproductive Medicine And Endocrinology, Houston, Texas

More information

Vertebral Fracture Assessment with Densitometry

Vertebral Fracture Assessment with Densitometry Vertebral Fracture Assessment with Densitometry Policy Number: 6.01.44 Last Review: 12/2018 Origination: 4/2005 Next Review: 6/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide

More information

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men Osteoporos Int (1999) 10:265 270 ß 1999 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Bone Mineral Density and Vertebral Fractures

More information

Dual-energy Vertebral Assessment

Dual-energy Vertebral Assessment Dual-energy Vertebral Assessment gehealthcare.com Dual-energy Vertebral Assessment More than 40% of women with normal or osteopenic BMD had a moderate or severe vertebral deformation seen with DVA. Patrick

More information

Advanced DXA Using TBS insight

Advanced DXA Using TBS insight Advanced DXA Using TBS insight A New Bone Structure Assessment Technique Enhances Identification of Fracture Risk Introduction The World Health Organization defines osteoporosis as asilent disease characterised

More information

Using GE Lunar DXA to Quantify, Visualize, and Trend Incipient Atypical Femoral Fractures

Using GE Lunar DXA to Quantify, Visualize, and Trend Incipient Atypical Femoral Fractures Using GE Lunar DXA to Quantify, Visualize, and Trend Incipient Atypical Femoral Fractures The management of osteoporosis underwent a paradigm shift in 1995 with the approval of the first bisphosphonate,

More information

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:

More information

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS 4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending

More information

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits

More information

Fall-related risk factors and osteoporosis in older women referred to an open access bone densitometry service

Fall-related risk factors and osteoporosis in older women referred to an open access bone densitometry service Age and Ageing 05; 34: 67 71 Age and Ageing Vol. 34 No. 1 British Geriatrics Society 04; all rights reserved doi:10.1093/ageing/afh238 Published electronically 15 November 04 Fall-related risk factors

More information

Study of secondary causes of male osteoporosis

Study of secondary causes of male osteoporosis Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos

More information

A prospective evaluation of bone mineral density measurement in females who have fallen

A prospective evaluation of bone mineral density measurement in females who have fallen Age and Ageing 2003; 32: 497 502 Age and Ageing Vol. 32 No. 5 British Geriatrics Society 2003; all rights reserved A prospective evaluation of bone mineral density measurement in females who have fallen

More information

The DXL Calscan heel densitometer: evaluation and diagnostic thresholds

The DXL Calscan heel densitometer: evaluation and diagnostic thresholds The British Journal of Radiology, 79 (2006), 336 341 The DXL Calscan heel densitometer: evaluation and diagnostic thresholds J A THORPE, MSc, BSc and S A STEEL, MSc, BSc Centre for Metabolic Bone Disease,

More information

ACCURATE IDENTIFICATION of individuals at risk for

ACCURATE IDENTIFICATION of individuals at risk for 0021-972X/07/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 92(1):77 81 Printed in U.S.A. Copyright 2007 by The Endocrine Society doi: 10.1210/jc.2006-1415 Effectiveness of Bone Density Measurement

More information

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Objectives Review osteoporosis

More information

Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry

Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry Bone Mineral Densitometry with Dual Energy X-Ray Absorptiometry R Gilles, Laurentius Ziekenhuis Roermond 1. Introduction Osteoporosis is characterised by low bone mass, disruption of the micro-architecture

More information

DEXA T-score Concordance and Discordance Between hip and Lumbar Spine

DEXA T-score Concordance and Discordance Between hip and Lumbar Spine Abstract DEXA T-score Concordance and Discordance Between hip and Lumbar Spine Jang-Suk Choi, MD, Ki-Chan An, MD, Chang-Seop Lee, MD Jong-Moon Choi, MD, Joo Yong Kim, MD, Dong-Reol Shin, MD* Department

More information

QDR Series. Discovery and Explorer Advanced Health Assessment

QDR Series. Discovery and Explorer Advanced Health Assessment O S T E O P O R O S I S A S S E S S M E N T QDR Series Discovery and Explorer Advanced Health The Hologic QDR Series bone densitometers combine the proven clinical value of bone mineral density (BMD) measurement

More information

Lunar idxa. The intelligent DXA. gehealthcare.com

Lunar idxa. The intelligent DXA. gehealthcare.com Lunar idxa The intelligent DXA gehealthcare.com The best of DXA technology for bone and metabolic health assessment With a state-of-the-art design, Lunar idxa offers research-grade image resolution and

More information

Pharmacy Management Drug Policy

Pharmacy Management Drug Policy Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community. Guidelines

More information

Lunar Prodigy Advance

Lunar Prodigy Advance GE Medical Systems Lunar Prodigy Advance Direct-Digital Densitometry imagination at work Your practice needs to move fast, yet you want peace of mind. A partnership is a journey - expertise, support and

More information

Beyond the T-score: New Thinking in Osteoporosis 2

Beyond the T-score: New Thinking in Osteoporosis 2 Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/beyond-the-t-score-new-thinking-in-osteoporosis-

More information

Clinical Appropriateness Guidelines: Advanced Imaging

Clinical Appropriateness Guidelines: Advanced Imaging Clinical Appropriateness Guidelines: Advanced Imaging Appropriate Use Criteria: Quantitative CT (QCT) Bone Mineral Densitometry Effective Date: September 5, 2017 Proprietary Date of Origin: 05/21/2007

More information

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

Advanced medicine conference. Monday 20 Tuesday 21 June 2016 Advanced medicine conference Monday 20 Tuesday 21 June 2016 Osteoporosis: recent advances in risk assessment and management Juliet Compston Emeritus Professor of Bone Medicine Cambridge Biomedical Campus

More information

Skeletal Manifestations

Skeletal Manifestations Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes

More information

Interobserver Reproducibility of Criteria for Vertebral Body Exclusion

Interobserver Reproducibility of Criteria for Vertebral Body Exclusion JOURNAL OF BONE AND MINERAL RESEARCH Volume 20, Number 3, 2005 Published online on November 29, 2004; doi: 10.1359/JBMR.041134 2005 American Society for Bone and Mineral Research Interobserver Reproducibility

More information

A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model

A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model J Bone Metab 15;:113-11 http://dx.doi.org/.15/jbm.15..3.113 pissn 7-375 eissn 7-79 Original Article A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model

More information

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one

More information

Screening for Vertebral Fracture with Dual X-ray Absorptiometry (DXA)

Screening for Vertebral Fracture with Dual X-ray Absorptiometry (DXA) Medical Policy Manual Radiology, Policy No. 48 Screening for Vertebral Fracture with Dual X-ray Absorptiometry (DXA) Next Review: March 2018 Last Review: April 2017 Effective: May 1, 2017 IMPORTANT REMINDER

More information

Whole Body Dual X-Ray Absorptiometry to Determine Body Composition

Whole Body Dual X-Ray Absorptiometry to Determine Body Composition Page: 1 of 6 Last Review Status/Date: March 2015 Determine Body Composition Description Using low dose x-rays of two different energy levels, whole body dual x-ray absorptiometry (DXA) measures lean tissue

More information

Osteoporosis Screening and Treatment in Type 2 Diabetes

Osteoporosis Screening and Treatment in Type 2 Diabetes Osteoporosis Screening and Treatment in Type 2 Diabetes Ann Schwartz, PhD! Dept. of Epidemiology and Biostatistics! University of California San Francisco! October 2011! Presenter Disclosure Information

More information

Ghada El-Hajj Fuleihan, MD,MPH.

Ghada El-Hajj Fuleihan, MD,MPH. Ghada El-Hajj Fuleihan, MD,MPH. Dr El-Hajj Fuleihan is Professor of Medicine and Founder and Director of the Calcium Metabolism and Osteoporosis Program at the American University of Beirut Medical Center.

More information

Foreword...v Preface...vii Acknowledgments... xi Dedication... xiii Continuing Medical Education... xxv. Chapter 1: Densitometry Techniques...

Foreword...v Preface...vii Acknowledgments... xi Dedication... xiii Continuing Medical Education... xxv. Chapter 1: Densitometry Techniques... CONTENTS Foreword...v Preface...vii Acknowledgments... xi Dedication... xiii Continuing Medical Education... xxv Chapter 1: Densitometry Techniques... 1 Plain Radiography in the Assessment of Bone Density...

More information

SCHEDULE 2 THE SERVICES. A. Service Specifications

SCHEDULE 2 THE SERVICES. A. Service Specifications SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No. 04/MSKT/0013 Service PAN DORSET FRACTURE LIAISON SERVICE Commissioner Lead CCP for Musculoskeletal & Trauma Provider Lead Deputy

More information

Using the FRAX Tool. Osteoporosis Definition

Using the FRAX Tool. Osteoporosis Definition How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX

More information

Omnisense: At Least As Good As DXA

Omnisense: At Least As Good As DXA Omnisense: At Least As Good As DXA The following document summarizes a series of clinical studies that have been conducted to compare between different qualities of the Sunlight support the claim that

More information

Bone mineral density testing: Is a T score enough to determine the screening interval?

Bone mineral density testing: Is a T score enough to determine the screening interval? Interpreting Key Trials CME CREDIT EDUCATIONAL OBJECTIVE: Readers will measure bone mineral density at reasonable intervals in their older postmenopausal patients Krupa B. Doshi, MD, CCD Department of

More information

CLINIQCT NO-DOSE CT BONE DENSITOMETRY FOR ROUTINE AND SPECIALIST USE.

CLINIQCT NO-DOSE CT BONE DENSITOMETRY FOR ROUTINE AND SPECIALIST USE. CLINIQCT NO-DOSE CT BONE DENSITOMETRY FOR ROUTINE AND SPECIALIST USE Clinically superior BMD solutions for physicians DXA equivalent hip measurements Dual-use of standard abdominal or pelvic CT studies

More information